While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna Ella said, "In the beginning, the cost of vaccine may be a little higher.
As the scale of production increases, the price will be controlled by market."
